Skip to main content
Clinical Trials/IRCT20240409061460N1
IRCT20240409061460N1
Recruiting
未知

Comparison of the effect of intravesical injection of Botox with oral tamsulosin 0.4 mg in the treatment of lower urinary tract symptom disorders (LUTS) in patients with symptomatic benign prostatic hyperplasia (BPH).

Ahvaz University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\- Prostate volume more than 30 ml
  • 2\- Obtaining a score higher than 8 from the International Prostate Symptom Score (IPSS)
  • 3\- Serum level total prostate specific antigen (tPSA) less than 10ng/mL
  • 4\- maximum urinary flow rate (Qmax) less than 16 ml/s
  • 5\- Voided volume (VV) more than 150 ml

Exclusion Criteria

  • 1\- Having an active and recurrent urinary tract infection
  • 2\- History of previous prostatectomy
  • 3\- History of prostate cancer
  • 4\- Bladder or prostate stones
  • 5\- History of using phenylephrine, pseudoephedrine, imipramine, cholinergic, anticholinergic, estrogen, androgen and steroid since 4 weeks before the intervention
  • 6\- Biopsy from 6 weeks before the intervention
  • 7\- History of unstable angina pectoris, primary neurological disease that affects bladder function, such as multiple sclerosis, myasthenia gravis, Parkinson's
  • 8\- History of BoNT\-A intraprostatic administration
  • 9\- Taking ASA, warfarin and NSAIDs from 6 days before the intervention
  • 10\- History of bladder sensitivity to BoNT\-A

Outcomes

Primary Outcomes

Not specified

Similar Trials